We live in an era of tremendous scientific advancement and promise for better human health. With the increased identification of novel targets and their related modalities, our understanding of biology is rapidly expanding. Despite this, drug research costs and timeframes are increasing, and the likelihood of success is decreasing. We feel that the moment has come for a fundamental paradigm shift in medication development. Using artificial intelligence, we are focused to find antibiotic resistance solutions.